Skip to main content
FDA clears syphilis assay from Bio-Rad

The FDA has given Bio-Rad Laboratories clearance for its BioPlex 2200 Syphilis Total & RPR assay, a fully automated Treponemal/non-Treponemal dual test intended for the diagnosis of syphilis infection. The assay allows for simultaneous detection of antibodies to T. pallidum and reagin antibodies and rapid plasma reagin titer determination to facilitate treatment monitoring.

Full Story: